儿童风湿病相关巨噬细胞活化综合征单中心临床研究  被引量:2

Clinical study of juvenile rheumatic disease-associated macrophage activation syndrome:A retrospective study from a single center

在线阅读下载全文

作  者:徐莉[1] 何胜男 张宇[1] 罗冲[1] 刘明月[1] 王雅婷[1] 汪利 唐雪梅[1] XU Li;HE Sheng-nan;ZHANG Yu(Department of Rheumatology and Immunology,Children’s Hospital of Chongqing Medical University,Ministry of Education Key Laboratory of Child Development and Disorder,China International Science and Technology Cooperation Base of Child Development and Critical Disorders,National Clinical Research Center for Child Health and Disorders,Chongqing Key Laboratory of Child Infection and Immunity,Chongqing400014,China)

机构地区:[1]重庆医科大学附属儿童医院风湿免疫科,儿童发育疾病研究教育部重点实验室,国家儿童健康与疾病临床医学研究中心,儿童发育重大疾病国家国际科技合作基地,儿童感染免疫重庆市重点实验室,重庆400014

出  处:《中国实用儿科杂志》2021年第4期285-291,共7页Chinese Journal of Practical Pediatrics

摘  要:目的总结儿童风湿病相关巨噬细胞活化综合征(MAS)临床和实验室特征、治疗及转归。方法回顾性分析2008年1月至2019年11月重庆医科大学附属儿童医院75例MAS患儿的临床和实验室特征、治疗及转归。结果MAS的基础疾病包括全身型幼年特发性关节炎(SJIA)32例、系统性红斑狼疮(SLE)22例、川崎病(KD)15例、幼年皮肌炎(JDM)5例和混合结缔组织疾病(MTCD)1例。常见的临床症状有发热(100%)、肝大(73.3%)、脾肿大(49.3%)、神经系统症状(45.3%)、淋巴结肿大(42.7%)、出血(24.0%)。实验室检查显示三系下降,铁蛋白、转氨酶、乳酸脱氢酶、三酰甘油升高,纤维蛋白原降低。糖皮质激素冲击治疗和非冲击治疗在体温恢复正常时间及死亡比例方面差异无统计学意义。13例死亡,死亡组患儿出血、神经系统受累及呼吸衰竭发生率更高,纤维蛋白原及NK细胞更低。结论风湿病患儿出现发热、肝脾肿大、血常规下降、铁蛋白升高需警惕MAS发生。出血、神经系统受累、严重低纤维蛋白原血症提示预后不良。糖皮质激素仍是治疗首选,剂量选择有待进一步研究。Objective To study the clinical and laboratory features,treatment and outcome of rheumatic disease-associated macrophage activation syndrome(MAS)in children.Methods We retrospectively analyzed the clinical and laboratory features,treatment and outcome of 75 patients with juvenile rheumatic disease-associated MAS.Results Of the 75 MAS patients,32 with systemic juvenile idiopathic arthritis(SJIA),22 with systemic lupus erythematosus(SLE),15 withKawasaki disease(KD),5 with juvenile dermatomyositis(JDM)and 1 with mixed connective tissue disease(MCTD)as primary diseases.The common clinical symptoms included fever(100%),hepatomegaly(73.3%),splenomegaly(49.3%),nervous system symptoms(45.3%),lymph node enlargement(42.7%)and hemorrhagic manifestations(24%).There were decreases in white blood cell,platelet,hemoglobin and fibrinogen,and increases in serum ferritin,transaminase,lactate dehydrogenase and triglyceride.There was no significant difference between glucocorticoid pulse therapy and non-pulse therapy in the time of fever clearance or the proportion of death.There were 13 deaths in this group.The incidence of bleeding,nervous system involvement and respiratory failure was higher in the death group,and the death group had lower levels of fibrinogen and NK cells.Conclusion If patients with rheumatic disease have persistent fever,hepatosplenomegaly,decreases in white blood cell,platelet and hemoglobin and increase in serum ferritin,the development of MAS should be considered.Bleeding,nervous involvement and severe hypofibrinogenemia suggest poor prognosis.Glucocorticoid therapy remains the first choice in the treatment of MAS,but the dose needs further study.

关 键 词:巨噬细胞活化综合征 全身型幼年特发性关节炎 系统性红斑狼疮 川崎病 儿童 

分 类 号:R72[医药卫生—儿科]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象